Seattle Angel Conference 27 Final Demo Day program
Watch on
The 27th Seattle Angel Conference event is the final "Demo Day" for a combination of new investors and very early startups. Of the 79 companies that applied, 6 have made the finals. Over the last month, those finalist companies have been reviewed and evaluated by the investors. Our investors have been working together to understand the current state of each company. They have also put together a fund of up to $200K that will be invested in one of these companies. This program is the culmination of 3 months of work by the investors in the fund. Join us to see what they think about the early stage companies that are participating. If you are "Accredited" and are interested in learning more about the Angel Investing process, or if you are an early startup thinking about outside funding of your company this program will help you connect with new investors, get perspective on the state of the early startup process and give you insights for how you can succeed with that fundraising process. Our finalists for this round are: Cetae/ Emerald Battery Cetae is revolutionizing sodium-ion technology through materials and device innovation. Drive Hockey Analytics AI-powered sports performance data company supporting amateur and recreational athletes using cutting edge sensor and smart-arena technology. https://drivehockey.com INIA Biosciences Wearable therapy device to modulate the immune system in patients with psoriasis. http://iniabiosciences.com Kilele Health Inc. Wearable blood chemistry sensors to shift chronic disease care from crisis-based to status-based. https://www.kilelehealth.com Truss Health "AI-powered medical device platform to early detect surgical site infections for out of hospital patients" [https://www.TrussHealth.ai](https://www.trusshealth.ai) Vistim Labs Inc Brain mapping software for routine dementia disease monitoring, enabling doctors to provide better care and earn more money. http://vistimlabs.com